JAX Antibody Development Summit - Jan Terje Andersen
Fill form to unlock content
Loading, please wait
Error - something went wrong!
Access the On-Demand Video
Thank you!
Dr. Jan Terje Andersen, Professor, University of Oslo, presents FcRn as a Target for Engineering of Albumin-Based Biologics with Favorable In Vivo Properties as part of The Jackson Laboratory's Antibody Drug Development Summit.